Adiagnosis	O	0,10
of	O	11,13
Lyme	B-KP	14,18
neuroborreliosis	I-KP	19,35
was	O	36,39
confirmed	O	40,49
thereafter	O	50,60
by	O	61,63
positive	O	64,72
serologic	O	73,82
findings	O	83,91
on	O	92,94
both	O	95,99
enzyme-linked	B-KP	100,113
immunosorbent	I-KP	114,127
assay	I-KP	128,133
(	O	134,135
ELISA	B-KP	135,140
)	O	140,141
and	O	142,145
Western	B-KP	146,153
blot	I-KP	154,158
.	O	158,159

The	O	160,163
patient	O	164,171
refused	O	172,179
lumbar	O	180,186
puncture	O	187,195
for	O	196,199
cerebrospinal	B-KP	200,213
fluid	I-KP	214,219
analysis	I-KP	220,228
.	O	228,229

He	O	230,232
was	O	233,236
started	O	237,244
on	O	245,247
an	O	248,250
intravenous	B-KP	251,262
ceftriaxone	I-KP	263,274
regimen	O	275,282
on	O	283,285
hospital	O	286,294
day	O	295,298
6	O	299,300
.	O	300,301

His	O	302,305
clinical	O	306,314
condition	O	315,324
and	O	325,328
functional	O	329,339
status	O	340,346
promptly	O	347,355
improved	O	356,364
.	O	364,365

At	O	366,368
discharge	O	369,378
on	O	379,381
hospital	O	382,390
day	O	391,394
10	O	395,397
,	O	397,398
he	O	399,401
needed	O	402,408
close	O	409,414
supervision	O	415,426
for	O	427,430
ADL	B-KP	431,434
and	O	435,438
transfer	O	439,447
,	O	447,448
and	O	449,452
ambulated	O	453,462
250	O	463,466
feet	O	467,471
with	O	472,476
improved	O	477,485
gait	O	486,490
.	O	490,491

The	O	492,495
patient	O	496,503
had	O	504,507
regained	O	508,516
full	O	517,521
left	O	522,526
UE	O	527,529
strength	O	530,538
and	O	539,542
functional	O	543,553
independence	O	554,566
at	O	567,569
the	O	570,573
end	O	574,577
of	O	578,580
the	O	581,584
4-week	O	585,591
antibiotic	O	592,602
therapy	O	603,610
.	O	610,611

